Targeting the PD-1/PD-L1 axis in the treatment of lung cancer.
- Published in:
- Forum of Clinical Oncology, 2016, v. 7, n. 1, p. 17, doi. 10.1515/fco-2015-0021
- By:
- Publication type:
- Article
Works matching IS 1792345X AND DT 2016 AND VI 7 AND IP 1
Results: 4
1
2
The expanding new era of cancer immunotherapy.
- Published in:
- Forum of Clinical Oncology, 2016, v. 7, n. 1, p. 1, doi. 10.1515/fco-2016-0003
- By:
- Publication type:
- Article
3
Overview and management of toxicities of immune checkpoint-blocking drugs.
- Published in:
- Forum of Clinical Oncology, 2016, v. 7, n. 1, p. 28, doi. 10.1515/fco-2016-0004
- By:
- Publication type:
- Article
4
Reinstating endogenous antitumor immunity: The concept of therapeutic management of cancer.
- Published in:
- Forum of Clinical Oncology, 2016, v. 7, n. 1, p. 4, doi. 10.1515/fco-2016-0005
- By:
- Publication type:
- Article